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Purpose: To analyze the rabbit host global gene expression patterns in uninfected and herpes simplex virus type 1 (HSV-1)
latent trigeminal ganglia (TG) for identification of host response-initiated transcriptional changes during the maintenance
of viral latency.
Methods: The corneas of eight-week-old New Zealand White rabbits were scarified and inoculated with HSV-1 strain
McKrae, 5x105 plaque forming units/eye. Corneal infection was verified by slit-lamp examination. Prior to sacrifice at 30
days post infection, ocular swabs confirmed no infectious virus was present. TG were aseptically removed from rabbits
and placed in RNA stabilization solution. Host RNA was isolated from two groups of TG, uninfected and HSV-1 latent
infected, and used to create labeled cRNA. Labeled cRNA was hybridized to two new and novel custom oligonucleotide
rabbit arrays, containing a total of 3,123 probes for rabbit genes.
Results: The rabbit TG expressed approximately 80% of genes out of a total of 3,123. A one-way ANOVA performed
on the log2 transformed signal ratios showed 611 genes were significantly altered (p≤0.05) in HSV-1 latent TG. These
genes, if annotated, were separated by biologic process categories. Five broad categories were most heavily represented:
protein processing, carbohydrate processing, cell adhesion, apoptosis, and host defense and immune response. Sixty of
the significantly altered genes were found to be altered by more than 2 fold, and five were altered by more than 4 fold.
The genes altered by more than 4 fold were all upregulated and related to host defense and immune response. Viral latency
had a large effect on protein processing. Of the differentially expressed genes with an assigned biologic process, 90/349
(25.7%) were associated with protein processing. The next most populated categories were carbohydrate metabolism
39/349 (11.1%) and host defense and immune response 17/349 (4.9%).
Conclusions: The results of this microarray study demonstrate that host gene expression is altered in the HSV-1 latent
rabbit TG. The shift in molecular processes at a pathway level reveals the presence of potential therapeutic significance
inherent in the maintenance of HSV-1 latency. This is the first large-scale rabbit gene expression study, using microarray
analysis, that documents the involvement of host immunity in maintaining HSV-1 latency.
A unique feature of herpes simplex virus (HSV) is its
ability to establish a permanent latent infection for the life of
the host [1,2]. During primary infection, HSV invades the
neurons  that  innervate  the  mucosal  surface  by  retrograde
axonal transport to the neuronal nuclei that are housed in the
sensory  ganglia.  In  animal  models,  HSV-1  infection  of
surrounding neurons is observed after the virus replicates
briefly  in  the  neurons  [3].  Latent  HSV  infection  is  then
established in which functional viral genomes are retained in
neuronal nuclei. HSV DNA persists in sensory ganglia of the
peripheral  nervous  system  [4]  and  is  characterized  by
occasional  reactivation  of  infectious  virus.  This  could
manifest  as  deadly  brain  inflammation  or  outbreaks  of
mucocutaneous lesions at peripheral sites innervated by the
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infected ganglia [5]. Reactivation may be spontaneous (non-
induced)  or  triggered,  effected  mainly  by  host  factors,
including altered expression of cellular components such as
induction of transcriptional activators and downregulation of
repressors.  Factors  such  as  hormonal  changes,  stress,  and
ultraviolet (UV) exposure can induce the reactivation of the
latent  virus  [6-9].  Reactivation  can  also  be  triggered  by
systemic changes in immune modulators, physical probing,
and immunological or pharmacological induction of neuronal
and surrounding tissue [10-18]. Viral reactivation has been
triggered  by  stressors  including  epinephrine  iontophoresis
[15],  timolol  [19],  and  nicotine  [16]  in  rabbits,  and
cyclophosphamide and dexamethasone immunosuppression-
induction [10,13], sodium butyrate [17], and cadmium [20] in
mice.
During latency, expression of viral genes is suppressed,
with the exception of latency-associated transcripts that are
the only abundantly present viral transcripts in latent infected
neurons [21]. Latency, thus, has been described as a “passive
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1209phenomenon” due to lack of activation of the acute phase of
viral pathogenesis [21]. In contrast, early molecular events
during  reactivation  from  latency  suggest  a  more  dynamic
transcriptional  activity  [18,22].  However,  molecular
mechanisms in neuronal cells that regulate transformation
from acute infection to latency and influence the ability of the
virus to reactivate remain under investigation. There are also
species  differences  underlying  reactivation.  The  virus
undergoes spontaneous, episodic reactivation with or without
evidence  of  recurrent  disease  in  humans  and  rabbits.  In
contrast, mice either do not undergo spontaneous reactivation
or undergo spontaneous reactivation at such a low frequency
or low amount that it is difficult to detect [23].
The pathways of HSV-1 acute phase or lytic infection are
well  understood.  Although  the  contribution  of  the  host
immune system to maintaining the viral genome in a latent
state  is  known,  the  actual  processes  resulting  in  the
establishment, maintenance, and reactivation from latency are
largely  unclear  [24].  Microarray  analysis  of  host  gene
expression in response to viral infection is increasingly being
used to more comprehensively assess genetic function and
cellular  response.  Altered  host  gene  expression  has  been
demonstrated with varying patterns of expression evident with
increasing  time  following  hyperthermia  of  latent  infected
mice [22,25].
HSV infects the majority of the human population [26].
A high rate of viral shedding is prevalent as 98% of 50 human
subjects studied over 30 days have been reported to have each
shed HSV-1 viral DNA at least once over this time period
[27]. Thus, there is a high transmission rate and prevalence of
the virus in the world population [24]. In most individuals the
virus appears to be “immobilized” in the latent state. However,
in  some  individuals  outbreaks  are  frequent  and  probably
parallel  molecular  and  cellular  changes  geared  toward
suppressing the reactivation of the virus [24]. To understand
pathways  with  potential  therapeutic  implications  that
influence  viral  latency,  we  infected  New  Zealand  White
(NZW)  rabbits  with  HSV-1  under  conditions  that  favor
latency for comparison to uninfected naïve controls. After the
rabbits  were  sacrificed,  the  trigeminal  ganglia  (TG)  were
aseptically removed and rapidly processed for transcripts. The
transcripts  were  used  to  elucidate  gene  expression  during
latency.
METHODS
Rabbits, viruses, infection, and removal of trigeminal ganglia:
All animal procedures followed the “Principles of Laboratory
Animal Care” (NIH publication No. 86–23, revised 1985)
using a protocol approved by the LSU Health Sciences Center
Institutional Animal Care and Use Committee. Ten eight-
week-old NZW rabbits (Black Creek Rabbitry, Moss Point,
MS) were conventionally housed (singly) in an Association
for Assessment and Accreditation of Laboratory Animal Care
accredited facility in stainless steel suburban surgical cages
under a 12:12 light dark cycle. Humidity was maintained
between  30  and  70%  and  temperature  at  61–72  οF  in  a
negatively pressured room with 10–15 air changes per hour.
The rabbits were given Harlan global 2031 rabbit food and
water  ad  libitum.  The  rabbits  were  anesthetized  by
intramuscular  injection  using  50  mg/kg  ketamine
hydrochloride and 10 mg/kg xylazine (Vedco Inc., St. Joseph,
MD). The corneas were scarified and inoculated with 25 µl
HSV-1 strain McKrae, 5x105 plaque forming units (pfu)/eye,
or  PBS  for  uninfected  (naïve)  controls.  Slit-lamp
examinations and ocular swabs were performed two and three
days after viral inoculations to verify 100% corneal infection.
To  verify  that  latency  had  been  established  at  30  days
postinoculation,  we  cocultured  ocular  swabs  and  primary
rabbit kidney cells. All were found negative for infectious
virus.  Rabbits  were  anesthetized  as  described  and  then
euthanized  with  100  mg/kg  sodium  pentobarbital  by
intracardiac  injection.  The  crania  were  opened,  and  TG
aseptically  removed.  The  TG  were  stored  in  RNAlater®
(Ambion, Austin, TX) at −80 °C until ready for use.
RNA  Isolation  and  preparation  of  fluorescently  labeled
cRNA: Total RNA was extracted from TG using an RNeasy®
kit (Qiagen Sciences, Germantown, MD) and submitted to the
University  of  Florida’s  Interdisciplinary  Center  for
Biotechnology  Research  Gene  Expression  Core  Facility
(Gainesville, FL). Prior to target labeling, the purity of each
sample was evaluated using a 200 ng aliquot with a 2100
Bioanalyzer (Agilent Technologies, Palo Alto, CA). Purity
was assessed based on the relative abundance of the 18S and
28S ribosomal bands and on the presence of baseline rise, both
of which reveal RNA degradation. Samples were prepared for
hybridization according to the Low RNA Input Fluorescent
Linear Amplification Kit protocol (Agilent Technologies).
A 300 ng aliquot of total RNA was used as a template for
cDNA synthesis. The subsequent product served as a template
for in vitro transcription, during which one of two cyanine-
labeled  nucleotides  (Perkin  Elmer,  Wellesley,  MA)  was
incorporated  into  the  synthesized  cRNA.  All  eight
experimental  RNA  samples  were  labeled  with  cyanine  5-
TABLE 1. PRIMER SEQUENCE FOR REAL-TIME PCR ANALYSIS
Gene Primers (5’-3’)
IGJ F: TGAAGAGCCATTTGCTTCTCTGGG
R: ATGATCCTGGAAGTGATGCGGACA
IL1β F: AGCTCACCAGTGAGATGATGGCTT
R: TCATGTAATTGGGACCATCGGCCT
LYZ F: AGAGGTCTTGCTTCCCAGTCAACA
R: ACTCCCTTGTAGCCATCCAATCCA
CAP18 F: ACTTCAAGGAAGATGGGCTGGTGA
R: TGTTGCAGCGGATGTCAAAGGAGT
CRISP3 F: GCCCTGATCACTGTGACAATGGACTA
R: CAGCTGGCCTTGCAGTTGTTCTTA
RPL27A F: ACACGGGTAAATGCTGCCAAGAAC
R: TTGGGAGCTTTCCCTTTCCCAGAA
GAPDH F: GAACATCATCCCTGCATCCA
R: CCAGTGAGCTTCCCGTTCA
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1210cytosine triphosphate. A reference RNA sample was prepared
by pooling an aliquot from each of the eight samples. The
reference  RNA  was  labeled  with  cyanine  3-cytosine
triphosphate.  In  vitro  transcription  reactions  were  cleaned
with RNeasy® Mini columns (Qiagen, Valencia, CA), and
cRNA concentration and specific activity were both measured
with  a  ND-1000  spectrophotometer  (NanoDrop
Technologies, Wilmington, DE). The quality of each cRNA
sample was evaluated with emphasis on total yield, specific
activity of product, and by the presence of a smooth, mRNA-
shaped curve of an appropriate range in fragment size.
Array  hybridization  and  generation  of  expression  values:
Hybridization cocktails were prepared for each sample by
combining  a  100  ng  aliquot  of  the  cyanine  5-cytosine
triphosphate-labeled  experimental  sample  and  a  100  ng
aliquot  of  the  cyanine  3-cytosine  triphosphate-labeled
reference RNA with a high salt buffer. This mixture was
incubated at 60 °C for 30 min to fragment the labeled cRNA
into 30–200 base strands. The fragmented reaction mixture
was  used  to  hybridize  two  new  and  novel  custom
oligonucleotide  rabbit  arrays  (Agilent  Technologies)
manufactured  in  the  eight-pack  format  (eight  individually
hybridizable 1.5K arrays per piece of glass). A representation
of the array plates is shown in Appendix 1. Arrays were
hybridized at 60 °C for 17 h in a rotating oven and passed
through both a low and a high stringency wash according to
the manufacturer’s protocols, dried with filtered nitrogen gas,
and scanned for each of two wavelengths (green: 570, red:
670) with a G2505 B Scanner (Agilent Technologies). Signal
values were adjusted to account for both local background and
potential  differences  in  hybridization  intensity  across  the
array.  Signals  not  significantly  above  background  were
considered  negative.  Because  accurate  estimates  of  signal
ratios cannot be calculated if neither the red nor green signal
is  above  background,  a  gene  was  considered  present
(expressed under experimental conditions) only if both the red
and green signals from its representative probe were above
background  on  each  array.  If  considered  present,  a  log2
red:green signal ratio was calculated individually for each
probe on each array. Signal ratios were normalized and used
for  analysis  of  gene  expression.  Probes  for  housekeeping
genes  GAPDH  and  β-actin  (ACTB)  were  included  on  the
arrays as internal controls. Signal acquisition, evaluation, and
transformation  were  performed  with  Feature  (Cap  E)
Extraction software version 8.1 (Agilent Technologies).
Analysis of expression data: To determine the effect of HSV-1
latency  on  gene  expression,  we  performed  a  one-way
ANOVA on the log2 transformed red:green ratios for two
treatments  (naïve  TG  and  HSV-1  latent  TG)  and  four
replicates. Statistical tests were performed with AnalyzeIt
Tools.
For  each  unique  contig,  a  homology  search  was
performed  using  the  BLASTX  and  BLASTN  application
against the NCBI NR and NT databases, respectively. BLAST
results were parsed and stored in BlastQuest, a SQL database
developed  by  ICBR  that  facilitates  the  management  of
BLAST  results  and  Gene  Ontology  (GO)  Consortium
assigned biologic processes (Ophthalmic Gene Microarray
Project)  [28].  Although  each  probe  represents  a  unique
sequence, some genes are represented by multiple probes. For
the purpose of this manuscript each probe is referred to as a
gene.
Quantitative  real-time  polymerase  chain  reaction:  Gene
expression  levels  for  the  microarrays  were  validated  by
quantitative real-time polymerase chain reaction (real-time
PCR). The real-time PCR analysis was done on HSV-1 latent
rabbit TG and naïve TG RNA samples for six rabbit genes
shown in Table 1. Real-time PCR was concurrently done for
rabbit GAPDH and its expression served as an internal control.
All primer pairs for the six genes were specifically designed
and  synthesized  by  Integrated  DNA  Technologies,  (San
Diego, CA). Reverse transcription was primed with T7-Oligo
(dT) containing primer (Affymetrix Inc., Santa Clara, CA).
Real-time PCR was performed in a 20 µl volume containing
TABLE 2. SUMMARY OF GENES WITH AN ASSIGNED GENE ONTOLOGY TERM WHOSE EXPRESSION WAS SIGNIFICANTLY ALTERED IN THE HSV-1
LATENT TRIGEMINAL GANGLIA
Upregulated (total 20)
x=fold change
Downregulated (total 40)
x=fold change
4x 2x <2x 4x 2x <2x
Immune response and defense 535Protein degradation 009
Protein biosynthesis 013Protein biosynthesis 004
Glycolysis 001Carbohydrate metabolism 0518
Apoptosis 002Apoptosis 004
The total number of genes whose expression was altered in the HSV-1 latent trigeminal ganglia comprised genes that were
upregulated and genes that were downregulated. HSV-1 latency overall favored downregulation of genes in the catabolic
categories of protein degradation and carbohydrate metabolism.
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1211a solution of 1X DyNAmo Flash SYBR® green Master Mix
(Finzymes,  Keilaranta,  Espoo,  Finland),  0.5  µM  forward
primer, 0.5 µM reverse primer, and 1 µl cDNA or 20 ng
reverse transcribed total RNA. The reaction was run using a
four-step  protocol:  denaturation,  10  min  at  95  °C;
amplification and quantification, 40 cycles at 15 s for 95 °C
and at 1 min for 60 °C; melting curve, 60–95 °C with a heating
rate of 0.5 °C/s followed by cooling. The real-time reactions
were  done  using  MyiQ™  Single  Color  Real-Time  PCR
detection System (Bio-Rad, Hercules, CA). Amplicons of the
real-time  PCR  were  analyzed  using  2%  agarose  gel
electrophoresis and each product separated into a single sharp
band of the correct size. HSV-1 latent rabbit TG and naïve TG
samples  were  assayed  in  triplicate.  Relative  quantitative
expression levels were determined for each gene. All results
are expressed as an expression ratio of the HSV-1 latent TG
to naïve TG, normalized against GAPDH expression levels
using the 2-ΔΔC
T method [29].
RESULTS
Of  the  3,123  genes  on  the  two  new  and  novel  custom
oligonucleotide rabbit arrays (Agilent Technologies), 2,509
genes were expressed in our experimental conditions. A one-
way ANOVA was performed on the log2 transformed signal
ratios  which  identified  611  genes  whose  expression  was
significantly  altered  (p≤0.05)  in  HSV-1  latent  rabbit  TG
(Appendix  2  and  Appendix  3).  The  null  hypothesis  was
rejected if the ratio of the naïve and HSV-1 latent treatment
means was significantly different. When this list of genes was
further filtered on the basis of fold change, it was found that
the expression of 60 genes differed by more than 2 fold and a
subset within these 60 genes changed by more than 4 fold
(Table 2, Appendix 4, and Figure 1). Real-time PCR done for
six selected genes within these 60 genes mirrored a pattern of
fold change consistent with those of the arrays (Appendix 5).
Of these 60 genes, the expression of 20 increased (Table 3)
and 40 decreased (Appendix 6) relative to naïve tissue. The
Figure 1. Gene expression significantly
altered  in  the  rabbit  HSV-1  latent
trigeminal  ganglia  compared  to  naïve
(uninfected)  trigeminal  ganglia.  Pie
chart  of  gene  expression  significantly
altered  in  the  HSV-1  latent  rabbit
trigeminal  ganglia  compared  to  naïve
trigeminal  ganglia.  Host  defense  and
immune  response  genes  showed  the
highest percentage of altered genes that
were  upregulated.  The  catabolic
categories  of  protein  degradation  and
carbohydrate  metabolism  showed  the
highest percentage of altered genes that
were downregulated.
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1212genes whose expression changed by more than 4 fold were a
subset comprising five genes belonging to the 20 genes whose
expression increased (Appendix 2 and Table 4). These five
upregulated genes all had an assigned GO term of host defense
and  immune  response:  IL1β,  CRISP3,  CAP18,  lysozyme
(LYZ), and immunoglobulin joining chain (IGJ). Two more
genes within this group of 20 also had an assigned GO term
related  to  host  defense  and  immune  response:  major
histocompatibility  complex  class  II  DQ  alpha  1  (HLA-
DQA1) and amyloid A protein (SAA). An additional two genes
also belonging to these 20 genes, human chemokine ligand 12
(CXCL12), and antibody variable domain, could be assumed
to be involved in host defense and immune response based on
their gene nomenclature. In contrast, within the group of 40
downregulated  genes  (Appendix  6)  there  was  no  obvious
pattern in gene expression that would explain the maintenance
of viral latency. Figure 1 is a graphic representation of the
relative abundance of gene expression significantly altered in
the rabbit HSV-1 latent TG compared to naïve TG. Figure 1
shows  that  the  majority  of  the  genes  with  upregulated
expression are related to host defense and immune response,
while the majority of those with downregulated expression are
involved with carbohydrate metabolism.
To gain a more global perspective and potentially identify
metabolic shifts ongoing during HSV-1 latency, we filtered
TABLE 3. EXPRESSION OF 20 GENES SIGNIFICANTLY UPREGULATED IN THE RABBIT HSV-1 LATENT
TRIGEMINAL GANGLIA
Gene name Fold change
Immune response and defense
Immunoglobulin Joining Chain (IGJ) 14.22
Human Lysozyme (LYZ) 8.63
Cathelicidin Antimicrobial Peptide (CAMP) 6.06
Cysteine-rich Secretory Protein 3 (CRISP3) 4.23
Interleukin 1, Beta (IL1β) 4.2
Amyloid A Protein DSAA85 Precursor (SAA) 2.56
Major Histocompatibility Complex, Class II, DQ Alpha (HLA-DQA1) 2.89
Antibody Variable Domain-like 1 2.27
Antibody Variable Domain-like 2 1.99
Antibody Variable Domain-like 3 1.78
Antibody Variable Domain-like 4 1.45
Interleukin 1 Receptor Antagonist (IL1RA) 1.77
Ceruloplasmin (CP) 1.68
Protein biosynthesis
Ribosomal Protein L27a (RPL27A) 2.06
Ribosomal Protein S16 (RPS16) 1.59
Eukaryotic Translation Initiation Factor 3, Subunit 5 (EIF3F) 1.67
Eukaryotic Translation Initiation Factor 4A, Isoform (EIF4A1) 1.75
Glycolysis
Pyruvate Dehydrogenase E1 Component Beta Subunit, Mitochondrial
Precursor (PDHE1B)
1.13
Apoptosis
Thioredoxin Domain Containing (TXNDC) 1.85
Amyloid Beta Precursor Protein (APLP2) 1.4
Gene expression was significantly (p≤0.05) altered by more
than twofold in the HSV-1 latent rabbit trigeminal ganglia
(TG). Twenty expressed genes were significantly upregulated
in the rabbit HSV-1 latent TG of which a subset of five genes
in  the  immune  response  and  defense  category  were
upregulated  by  more  than  4  fold.  Immune  response  and
defense gene expression showed the highest upregulation in
the rabbit HSV-1 latent TG.
all the differentially expressed genes by their GO terms. Only
349 of the genes had an assigned GO term for biologic process.
The remaining 262 genes did not at the time of this study.
When separated by ontology, five heavily populated biologic
processes were identified: protein processing, carbohydrate
processing, cell adhesion, apoptosis, and host defense and
immune response (Appendix 3). Each category was further
broken down into subcategories based on more specific GO
terms.  Thus,  the  protein  processing  group  included  genes
representing  biosynthesis,  folding,  modification,  transport,
and proteolysis and peptidolysis (Appendix 2). Viral latency
had  a  large  effect  on  protein  processing  which  contained
90/349 (25.7%) of the differentially expressed genes with an
assigned biologic process ontology. The next most populated
categories were carbohydrate metabolism (39/349, 11.1%)
and  host  defense  and  immune  response  (17/349,  4.9%).
Examination of fold change values within ontology groups, in
some cases, identified shifts in metabolism. For example, of
the 2,509 genes that were considered expressed in our study,
121 represented genes involved in carbohydrate metabolism
and energy production (Appendix 7). Thirty-nine of these
genes were significantly affected by latency. Interestingly, 33
of the 39 were downregulated. Conversely, within the protein
biosynthesis group, 27 of the 33 expressed genes significantly
affected by latency were upregulated. Expression of all 23
genes associated with ribosomal proteins was upregulated.
Peripheral to the major shifts, 12 genes associated with protein
degradation were upregulated and five were downregulated.
Forty-two genes involved in apoptosis were expressed, of
which 11 were significantly altered, including seven genes
that  were  upregulated.  Forty-three  genes  involved  in  cell
adhesion  were  expressed  of  which  11  were  significantly
altered  including  only  three  genes  that  were  upregulated
(Appendix 7).
Gene expression levels were validated by performing
real-time  PCR  on  six  selected  genes.  The  changes  in
expression  levels  of  IGJ,  LYZ,  ribosomal  protein  L27a
(RPL27A), CRISP3, CAP18, and IL1β are listed in Appendix
5.  Of  these  six,  the  expression  of  only  IGJ  increased
dramatically—that is, greater than 40 fold. The increase in
expression of RPL27A, and CRISP3 of about 2 and 4 fold for
each gene, respectively, were almost identical in comparison
to the array-based expression changes. While the expression
of LYZ, CAP18, and IL1β increased moderately (about 3 fold),
this was comparably lower than the array-based expression
changes. Generally, the array-based expression changes were
consistent  with  those  of  the  real-time  PCR  in  that  the
expression of all six selected genes significantly increased,
and the trend of increment was maintained between the two
methods of detection. Thus, it follows that of the 3,123 genes
present on the arrays, IGJ had the highest increase in gene
expression, and this trend corresponds to the high value of the
real-time PCR. The values for the fold-change in expression
levels of RPL27A and CRISP3 for both the microarray and
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1213real-time  PCR  were  basically  the  same.  Further,  LYZ,
CAP18, and IL1β expression levels were all upregulated, but
to a lower extent in the real-time PCR than the microarray.
DISCUSSION
This study used two new custom oligonucleotide arrays [28]
to evaluate gene expression in the TG of rabbits harboring
latent  HSV-1.  Of  the  3,123  genes  on  the  two  arrays,  the
expression of 611 genes was altered during HSV-1 latency
when compared to the gene expression in the uninfected rabbit
TG.
During latency, the viral genome is stably maintained and
viral transcription is limited to the expression of latency-
associated transcripts. T-cell-secreted cytokines are believed
to  contribute  to  the  effective  establishment  of  latency  by
inducing host defense and immune response [30]. Considering
the supposed quiescent state of the TG during latency, there
is a relatively large proportion (approximately 20%) of genes
represented on the arrays that were differentially expressed.
This suggests a metabolically active interaction between the
functional viral genome and the TG harboring latent HSV-1
DNA. The interaction most likely to have a direct effect on
the  virus  is  that  dealing  with  host  defense  and  immune
response.  The  commitment  of  the  host  TG  to  defense  is
indicated by the percentage of defense and immune genes
whose  expression  was  significantly  increased  and  by  the
magnitude  of  the  increase.  Of  the  genes  that  were  most
affected during latency, 20 were upregulated (Table 2, Figure
1). Thirteen of these 20, including all five that changed by
more than 4 fold, are related to host defense and immune
response.
The first line of host defense and immune response is
innate and initiated by tissue damage. IL1β, which increased
4 fold, is a proinflammatory cytokine whose expression is
triggered by tissue injury or infection. IL1β stimulates and
mediates  the  hepatic  synthesis  and  subsequent  release  of
acute-phase  proteins  into  the  blood  stream  [31-33].  The
function of the acute-phase proteins is systemic, resulting in
the restoration of homeostasis, neutralization of pathogens,
and  promotion  of  conditions  necessary  for  tissue  repair
[31-34].  The  expression  of  three  acute-phase  proteins,
ceruloplasmin (CP), interleukin 1 receptor antagonist (IL1-
RN) and serum amyloid A protein (SAA) [32] was significantly
increased during latency (Appendix 2). CP, whose expression
increased by approximately 1.5 fold (68%) is believed to act
as an anti-inflammatory and an immunomodulatory agent.
The extrahepatic expression of CP is hypothesized to reduce
inflammation-induced  tissue  damage  [33].  IL1-RN,  which
increased by 1.75 fold (77%), binds to IL1 receptors and
inhibits the binding of both IL1-α and IL1β. As a consequence,
the biologic activity of these two cytokines is neutralized in
immune and inflammatory responses [35]. Also, CP is an
amyloid  precursor  protein  (APP)  gene.  APP  belongs  to  a
family  of  conserved  type  I  transmembrane  proteins.  This
family  includes  amyloid  beta  precursor-like  protein  2
(APLP2) [36-38]. The expression of APLP2 increased in the
HSV-1 latent rabbit TG (Appendix 2). SAA protein, which
increased by approximately 2.5 fold, is most similar to the
serum amyloid A3 (SAA3) isoform, which is the predominant
extrahepatic form in rats, mice, and rabbits [31,39]. SAA3 is
required  for  effective  stimulation  of  collagenase,  an
extracellular matrix repair enzyme, by IL1β in rabbit corneal
TABLE 4. SUBSET OF GENES WHOSE EXPRESSION WAS ALTERED MORE THAN 4 FOLD IN THE RABBIT HSV-1 LATENT TRIGEMINAL GANGLIA
Probe name p-value Mean log2
difference
Fold change Hit definition Biologic Process E-value
UF_Oc_c_40190 0.001 3.83 14.22 Immunoglobulin Joining
Chain
Humoral immune response 0
UF_Oc_c_40194 0.004 3.11 8.63 Human Lysozyme Cell wall catabolism; carbohydrate
metabolism; cytolysis
0
UF_Oc_n_41508 0.032 2.6 6.06 Cathelicidin Antimicrobial
Peptide
“Response to pest, pathogen or
parasite; defense response to
bacteria”
0
UF_Oc_c_40416 0.033 2.08 4.23 Cysteine-rich Secretory
Protein 3
Fertilization; innate immune
response; cell-cell adhesion;
spermatogenesis; defense response
0
UF_Oc_n_41565 0.021 2.07 4.2 Interleukin 1 Beta Apoptosis; cell proliferation;
negative regulation of cell
proliferation; signal transduction;
inflammatory response; regulation
of cell cycle; antimicrobial humoral
response
0
The genes whose expression was altered by more than 4 fold were all upregulated and had an assigned Gene Ontology term
related  to  host  defense  and  immune  response.  These  genes,  interleukin  1  beta  (IL1β),  cysteine-rich  secretory  protein  3
(CRISP3), cathelicidin antimicrobial peptide (CAP18), human lysozyme (LYZ), and immunoglobulin joining chain (IGJ), are
involved in innate and immune defense response.
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1214fibroblasts  [40].  Tumor  necrosis  factor-alpha  (TNF-α),  a
proinflammatory cytokine which is an important component
of  the  innate  response,  was  not  detected.  However,  its
modulator, TNF-αIP3 interacting protein 1 (TNIP1) decreased
in  the  TG  harboring  latent  HSV-1  (Appendix  2).  TNIP1
interacts with transcription factor TNF-αIP3 with an attributed
antiapoptotic  role  [41,42].  HSV-1  may  induce  this
antiapoptotic pathway to paralyze any deleterious effects of
IL1β.
In addition to acute-phase proteins, the expression of
other innate defense-related genes was significantly increased
during  HSV-1  latency.  CRISP3  expression  increased
approximately 4 fold (Table 3 and Appendix 4). Although its
function  is  not  well  established,  the  CRISP3  protein  is
localized together with lysozyme, collagenase, and gelatinase
in  human  neutrophils.  CRISP3  is  also  found  in  exocrine
secretions and is a major secretory product of macrophages,
indicating a role in innate immunity [43-48]. CAP18 is a
histatin. CAP18 is produced by epithelial cells. These cells
constitute the first line of defense against pathogens [49].
CAP18  has  been  demonstrated  to  bind  to  and  neutralize
lipopolysaccharide and lipoteichoic acid, both of which are
considered  to  be  mediators  of  inflammation  [50,51].
Additionally, CAP18 is a chemotactic factor for T cells and
dendritic cells. Lysozyme C (LYZ), which increased by 8 fold
(Table 3 and Appendix 4), is a proteolytic enzyme that is a
component  of  granules  of  neutrophils  and  is  the  major
secretory  product  of  macrophages.  LYZ  is  thought  to  be
directly involved in the defense against bacteria [43,44] due
to its ability to hydrolyze the constituent polysaccharides of
bacterial  cell  walls.  CRISP3  and  LYZ  are  implicated  in
neutralizing  pathogens,  and  all  these  immune  gene
expressions were significantly increased in the HSV-1 latent
rabbit TG.
The  immune  defense  response  is  the  second  line  of
defense against pathogenic challenge. As was seen with the
innate host response, the commitment of the host to immunity
was  indicated  by  the  percentage  of  defense  genes  whose
expression was significantly increased and by the magnitude
of the increase. Immunoglobulin joining chain was the gene
whose expression changed the most, approximately 14 fold
(Table 3). Immunoglobulin joining chain plays an important
role in polymerization and secretion of IgA, pentameric IgM,
and  polymeric  IgS  [52,53],  all  of  which  are  important
protection  from  exposure  to  microbes  in  circulating  body
fluids. Other immunity genes that were significantly increased
included a major histocompatibility complex gene and a gene
for the antibody variable domain for which there were four
individual genes (Appendix 2 and Appendix 4). The 14 fold
increase  of  the  immunoglobulin  joining  chain  gene
expression,  together  with  the  high  percentage  increase  in
expression of other host defense and immune response genes,
indicates that the host immunity is activated to counter viral
infiltration. HSV-1, to evade this heightened surveillance,
probably imposes latency. Thus, the virus reverts to functional
viral genome that is retained in neuronal nuclei in an inactive
state to prevent its elimination by the host immune system.
Alternatively, HSV-1 circumvents the host immune response
by adapting to host immune mechanisms that seek to eliminate
the virus [54].
Although  the  host  defense  and  immune  response
functional group was the largest represented by genes whose
pattern  of  expression  changed,  shifts  in  other  metabolic
pathways  were  observed.  For  example,  of  the  protein
biosynthesis  genes  considered  expressed,  33/152  (21.7%)
were significantly affected by HSV-1 latency. Within this
group,  all  23  genes  associated  with  ribosomal  proteins,
including the subset of four genes associated with ribosome
biogenesis,  were  upregulated  (Appendix  7).  Ribosome
biogenesis  is  a  complex,  highly  coordinated  and  energy
intensive process. Because ribosome biogenesis is a major
consumer of the cell’s resources, upregulation of ribosome
biogenesis  only  occurs  when  extracellular  conditions  are
favorable  for  rapid  growth.  This  information  is  signaled
through  and  regulated  by  the  target  of  rapamycin  (TOR)
protein family. This family of proteins is highly conserved
within eukaryotes and has a COOH-terminal kinase domain
that phosphorylates serine and threonine residues [55,56].
Inhibition  of  TOR  signaling  by  rapamycin  causes  global
repression in the expression of genes coding for cytoplasmic
ribosome proteins [57].
In  addition  to  ribosome  biogenesis,  TOR  signaling
controls several other processes that are important for cell
growth [56]. These processes include transcription, protein
kinase C signaling, protein synthesis, protein degradation,
membrane  trafficking,  and  organization  of  the  actin
cytoskeleton.  Thus,  by  regulating  these  processes,  TOR
signaling  appears  to  control  the  balance  between  protein
synthesis  and  degradation  in  concert  with  extracellular
conditions  [56].  In  this  study,  we  found  that,  for  the
significantly altered expression of genes, 23/23 (100%) of the
genes  coding  for  ribosomal  proteins  were  upregulated,
suggesting favorable conditions for growth (Appendix 2 and
Appendix  7).  Consistent  with  this  idea,  we  found  12/17
(70.6%)  of  the  differentially  expressed  genes  coding  for
protein degradation decreased (Appendix 2 and Appendix 7).
In conjunction, we found that many of the expressed genes
that were associated with protein processing, transport 10/33
(30.3%),  folding  15/38  (39.5%)  and  modification  15/69
(21.7%), were significantly altered (Appendix 7). All these
results suggest a coordinated enhancement of the mechanism
involved in cell growth.
Contrary to the direction of shifts observed in protein
processing,  we  found  an  opposing  shift  in  carbohydrate
processing. Thirty-nine of the 121 genes representing genes
involved  in  carbohydrate  metabolism  were  significantly
affected by HSV-1 latency. The majority, 33 of the 39, were
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1215downregulated.  This  is  remarkable  considering  that  the
biogenesis of ribosomes is energy expensive and upregulation
of all ribosomal protein transcripts suggests favorable growth
conditions.
There was also a shift in the pattern of expression of
apoptosis  related  genes.  Of  the  42  genes  associated  with
apoptosis  that  were  expressed,  seven  of  the  11  genes
significantly  altered  by  HSV-1  latency  were  upregulated
(Appendix 2 and Appendix 7). This seems peripheral to the
observed shift in protein metabolism. However, apoptosis is
also a process that maintains a balance between synthesis and
degradation. Changes in apoptosis, affecting processes such
as proteolysis and transport, and components of the apoptotic
cell could possibly be recycled.
A shift in expression of genes related to cell adhesion was
also observed. Only three of the 43 expressed genes associated
with cell adhesion were upregulated (Appendix 7), although
cell adhesion activity is important for interactions that allow
viruses and bacteria to cause damage to tissues. Fibronectin
(FN) gene expression was decreased significantly (Appendix
2). FN is involved in many cellular processes, including tissue
repair, embryogenesis, blood clotting, cell migration and cell
adhesion. A major function of FN is in the adhesion of cells
to extracellular matrix materials, particularly collagen, and its
presence is crucial in tissue repair [58]. Since the alterations
in  gene  expressions  of  procollagen-Type  XII  alpha  1
(Col12a1)  gene,  which  increased  (Appendix  4),  and  FN,
which decreased, were antagonistic, healing of tissue could be
impaired—a condition that may be host-induced to delay viral
spread.
Global  gene  expression  assays  using  microarrays  are
becoming  standard  techniques  to  study  the  cellular  and
molecular response of the host cell during HSV reactivation.
However,  this  study  is  unique  as  an  analogous  study  has
analyzed host gene expression in the HSV-1 latent mouse TG
and during explantation [59]. This is the first rabbit study that
has used this approach to measure changes that may occur
during HSV-1 viral latency. Rabbits have been extensively
used as a model for HSV latency and reactivation in TG [60,
61]. However, the lack of a commercially available rabbit
array  has  hampered  the  implementation  of  global  gene
expression  research  in  rabbits.  This  study  attempts  to
illuminate  the  key  molecular  events  that  either  maintain
latency or are used during the suppression of viral genes. No
other animal study has focused exclusively on HSV-1 latent
infection  by  microarray  technology.  This  result  is
complementary  to  previous  studies  on  array  analysis  of
HSV-1 latent infected mouse TG [62], host gene response
during viral reactivation [22,63], and cyclophosphamide and
dexamethasone  immunosuppression-induction  reactivation
of HSV-1 [13].
The results of this study indicate that latency involves a
transcriptionally active response by the host. The most notable
response of the host during latency is a metabolic shift toward
protein  synthesis,  mediated  by  global  upregulation  of
transcripts  for  ribosomal  proteins,  and  a  reduction  in  the
transcript  level  of  genes  involved  in  protein  degradation.
Many genes coding for other proteins involved in protein
processing, (i.e., protein transport, protein modification, and
protein  folding)  were  significantly  altered.  Of  particular
interest is the fact that all gene expression changes by at least
fourfold were upregulated and related to immune response
and defense. This also suggests an active role of the host in
maintaining latency. This could also be brought about by lack
of  key  transcription  activation  factor(s).  It  has  been
demonstrated that a complex interplay of virus, neuron and
host  immune  surveillance  is  required  to  maintain  latency
[64].
Our selection of six genes (IGJ, LYZ, RPL27A, CRISP3,
CAP18, and IL1β) for performing real-time PCR, was made
because  of  the  importance  of  the  immune  response  and
defense genes in this study. Five of these six genes, with the
exception being RPL27A, belong to the defense category. In
validating the microarray data, the real-time PCR data also
provided confirmation that the immune response and defense
gene expression changes associated with the HSV-1 latent
rabbit  TG  are  significant.  The  consistency  and  trend  of
upregulation of each gene obtained by these two methods of
detection for all the six selected genes provide evidence of
significant HSV-1 latency-associated alteration of specific
genes  out  of  the  total  3,123  genes  present  on  the  arrays.
Although some of the levels were different between these two
methods of detection, we still observed the same trend of
upregulation of each gene. Comparison of the ratio of fold-
change values of gene expressions between the array and the
real-time PCR showed differences only in magnitudes with
some  relatively  minor:  IGJ,  +14.22:+44.32;  LYZ,
+8.63:+3.14; RPL27A, +2.06:+1.93; CRISP3, +4.23:+4.38;
CAP18, +6.06:+3.05; and IL1β, +4.20:+2.68. This suggests
that, overall, the microarray data were accurate. In support of
our observation, previous studies [13,59,65-69] have reported
changes in gene expression obtained from microarray analysis
as usually similar to, but not always identical with, those
obtained from real-time PCR [13,59,65,66]. Immunoglobulin
joining chain is important in the protection from exposure to
foreign antigens, and it is unclear whether its strikingly high
increase  in  expression  during  latency  is  a  direct  viral
manipulation  or  host  induced  response.  However,  this
phenomenon could be an indicator of the immune element’s
role in controlling the appearance of substantial viral proteins
that may lead to the initiation of the reactivation phase.
Overall, our microarray study, in which the expression of
genes associated with the host immune response and defense
were increased by more than 4 fold, indicates that the immune
system plays a significant role during the maintenance of
HSV-1  latency.  The  alterations  of  molecular  processes  in
which protein synthesis was upregulated as well as increases
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1216to major ribosomal proteins suggest the presence of pathways
for potential therapeutic intervention. This investigation of
global  gene  expression  shows  the  importance  of  host
immunity in the maintenance of HSV latency and provides
evidence for the significant transcription activity in HSV-1
latent rabbit TG.
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1219Appendix 1. A group of four images generated from scanned microarrays.
To access the data, click or select the words “Appendix
1”.
Each image is generated from a scanned single 1,900
element. Each circle represents a unique spotted probe. Red
genes indicate that gene expression in the rabbit HSV-1 latent
trigeminal ganglia (TG) is higher than in the control (naïve),
while  green  marks  higher  gene  expression  in  the  control.
Yellow indicates no difference in gene expression between
the  latent  infected  treated  and  control  TG.  Black  denotes
absence of detectable signal
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Appendix 2. Gene expression altered in rabbit trigeminal ganglia harboring
latent HSV-1
To access the data, click or select the words “Appendix
2”.
Genes  whose  expression  was  significantly  (p≤0.05)
altered by HSV latency. Mean log2 difference is the level of
gene expression in latent trigeminal ganglia (TG) compared
to naïve TG. The p-value represents the level of significance
in  treatment  means,  hit  definition  the  name  of  the  most
homologous gene and E-value the level of confidence that the
matched name is incorrect.
Appendix 4. Gene expression significantly altered by more than twofold in
the HSV-1 latent rabbit trigeminal ganglia
To access the data, click or select the words “Appendix
4”.
Gene expression significantly (p≤0.05) altered by more
than twofold in the HSV-1 latent rabbit trigeminal ganglia.
Mean log2 difference is the level of gene expression in HSV-1
latent trigeminal ganglia. The p-value represents the level of
significance in treatment means. Hit definition is the name of
the most homologous gene. E-value is the level of confidence
that the matched name is incorrect. Also listed are the Gene
Ontology Consortium terms for biologic process associated
with the most homologous gene.
Appendix 3. Genes significantly altered in rabbit HSV-1 latent trigeminal
ganglia according to their Gene Ontology for biologic process.
To access the data, click or select the words “Appendix
3”.
Genes  significantly  altered  in  rabbit  HSV-1  latent
trigeminal ganglia according to their Gene Ontology (GO) for
biologic  process.  The  most  heavily  populated  biologic
processes  included  protein  transport,  protein  biosynthesis,
protein  folding,  protein  modification,  proteolysis  and
peptidolysis,  carbohydrate  metabolism  and  energy
metabolism,  cell  adhesion,  apoptosis,  and  immune  and
defensive responses.Molecular Vision 2008; 14:1209-1221 <http://www.molvis.org/molvis/v14/a142> © 2008 Molecular Vision
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Appendix 7. Genes significantly altered in relation to the total number
expressed in the Gene Ontology Categories in the HSV-1 latent rabbit
trigeminal ganglia.
To access the data, click or select the words “Appendix
7”.
Genes significantly altered in relation to the total number
of genes expressed in the biologic process categories in the
rabbit  HSV-1  latent  trigeminal  ganglia.  Gene  expressions
showing the number of genes that significantly changed of the
total number expressed in percentages. Shifts in regulation of
the different metabolic processes show relative increases in
the  number  of  genes  involved  in  protein  metabolism
compared to carbohydrate metabolism. The asterisk indicates
Gene Ontology (GO), which are categories under which genes
were classified.
The print version of this article was created on 3 July 2008. This reflects all typographical corrections and errata to the article
through that date. Details of any changes may be found in the online version of the article.
Appendix 6. Expression of 40 genes significantly downregulated in the
rabbit HSV-1 latent trigeminal ganglia.
To access the data, click or select the words “Appendix
6”.
Gene expression was significantly (p≤0.05) altered by
more than 2 fold in the rabbit HSV-1 latent trigeminal ganglia
(TG).  Forty  expressed  genes  were  significantly
downregulated  in  the  rabbit  HSV-1  latent  TG.
Downregulation of genes in the rabbit HSV-1 latent TG were
mainly in the catabolic categories of protein degradation and
carbohydrate metabolism. There was no obvious pattern in
gene expression that would explain the maintenance of viral
latency.
Appendix 5. Rabbit HSV-1 Latent trigeminal ganglia gene expression array
means,  their  fold-changes  with  standard  deviations  and  corresponding
quantitative real-time polymerase chain reaction results of six selected
genes
To access the data, click or select the words “Appendix
5”.
Change in gene expression of six selected genes in HSV-1
latent  rabbit  trigeminal  ganglia  were  compared  to  naive
(control) based on microarrays (Array) and quantitative real-
time polymerase chain reaction. The mean log2 difference and
standard error of mean log2 difference (Microarray value) for
each of the selected genes is logarithmic and was obtained by
the averaging the difference between microarray values for
infected (L) and microarray values for naive (N) of each gene
before conversion. Listed are the corresponding processed red
and green signal values from the microarrays. The fold change
in  gene  expression  (Array  and  Quantitative  real-time
polymerase chain reaction) is arithmetic. Relative quantitative
expression levels were determined for each gene. All results
are  expressed  as  an  expression  ratio  of  the  HSV-1  latent
trigeminal ganglia to naive trigeminal ganglia, normalized
against housekeeping GAPDH expression levels using the 2-
ΔΔC
T  method  [29].  All  signal  values  of  the  arrays  are
distinguishable from background values, and most are high.
The raw red and green signal values for the approximately
3,000  genes,  55,000  values  are  available  on  the
Interdisciplinary Center for Biotechnology Research website.